Your browser doesn't support javascript.
loading
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM).
Ciardiello, D; Chiarazzo, C; Famiglietti, V; Damato, A; Pinto, C; Zampino, M G; Castellano, G; Gervaso, L; Zaniboni, A; Oneda, E; Rapisardi, S; Bordonaro, R; Zichi, C; De Vita, F; Di Maio, M; Parisi, A; Giampieri, R; Berardi, R; Lavacchi, D; Antonuzzo, L; Tamburini, E; Maiorano, B A; Parrella, P; Latiano, T P; Normanno, N; De Stefano, A; Avallone, A; Martini, G; Napolitano, S; Troiani, T; Martinelli, E; Ciardiello, F; De Vita, F; Maiello, E.
Affiliation
  • Ciardiello D; Oncology Unit, IRCCS Foundation Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; Medical Oncology Unit, Department of Precision Medicine, "Luigi Vanvitelli" University of Campania, Naples, Italy.
  • Chiarazzo C; Oncology Unit, IRCCS Foundation Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Famiglietti V; Medical Oncology Unit, Department of Precision Medicine, "Luigi Vanvitelli" University of Campania, Naples, Italy.
  • Damato A; Medical Oncology Unit, Comprhensive Cancer Center, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Pinto C; Medical Oncology Unit, Comprhensive Cancer Center, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Zampino MG; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy.
  • Castellano G; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy.
  • Gervaso L; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy.
  • Zaniboni A; Medical Oncology Unit, Poliambulanza Foundation, Brescia, Italy.
  • Oneda E; Medical Oncology Unit, Poliambulanza Foundation, Brescia, Italy.
  • Rapisardi S; Medical Oncology Unit, ARNAS Garibaldi, Catania, Italy.
  • Bordonaro R; Medical Oncology Unit, ARNAS Garibaldi, Catania, Italy.
  • Zichi C; Department of Oncology, University of Turin, A.O. Ordine Mauriziano, Turin, Italy.
  • De Vita F; Department of Oncology, University of Turin, A.O. Ordine Mauriziano, Turin, Italy.
  • Di Maio M; Department of Oncology, University of Turin, A.O. Ordine Mauriziano, Turin, Italy.
  • Parisi A; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy; Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.
  • Giampieri R; Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.
  • Berardi R; Department of Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.
  • Lavacchi D; Clinical Oncology Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Antonuzzo L; Clinical Oncology Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Tamburini E; Oncology Department and Palliative Care, Cardinale Panico, Tricase City Hospital, Tricase, Italy.
  • Maiorano BA; Oncology Unit, IRCCS Foundation Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, Rome, Italy.
  • Parrella P; Oncology Laboratory, Foundation Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo, Foggia, Italy.
  • Latiano TP; Oncology Unit, IRCCS Foundation Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Normanno N; Cellular Biology and Biotherapy, Istituto Nazionale Tumori, IRCCS-Fondazione G. Pascale, Naples, Italy.
  • De Stefano A; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori, IRCCS-Fondazione G. Pascale, Naples, Italy.
  • Avallone A; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori, IRCCS-Fondazione G. Pascale, Naples, Italy.
  • Martini G; Medical Oncology Unit, Department of Precision Medicine, "Luigi Vanvitelli" University of Campania, Naples, Italy.
  • Napolitano S; Medical Oncology Unit, Department of Precision Medicine, "Luigi Vanvitelli" University of Campania, Naples, Italy.
  • Troiani T; Medical Oncology Unit, Department of Precision Medicine, "Luigi Vanvitelli" University of Campania, Naples, Italy.
  • Martinelli E; Medical Oncology Unit, Department of Precision Medicine, "Luigi Vanvitelli" University of Campania, Naples, Italy.
  • Ciardiello F; Medical Oncology Unit, Department of Precision Medicine, "Luigi Vanvitelli" University of Campania, Naples, Italy. Electronic address: davide.ciardiello@unicampania.it.
  • De Vita F; Medical Oncology Unit, Department of Precision Medicine, "Luigi Vanvitelli" University of Campania, Naples, Italy.
  • Maiello E; Oncology Unit, IRCCS Foundation Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
ESMO Open ; 7(5): 100567, 2022 10.
Article in En | MEDLINE | ID: mdl-35994791
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Colonic Neoplasms Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Colonic Neoplasms Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article